Dana-Farber executive says split from Mass General will benefit patients

Laurie Glimcher trained at Massachusetts General Hospital. Her father was the chair of orthopedic surgery there, and her son is currently a thoracic surgeon at the hospital.

But Glimcher, the CEO of the neighboring Dana-Farber Cancer Institute, has no qualms about the contentious decision to sever a 30-year partnership with Massachusetts General’s parent organization.

The move will turn Dana-Farber and Mass General Brigham into competitors for cancer patients in the Boston area, and at the annual STAT Summit in Boston Wednesday, Glimcher asserted that it is actually a good change for patients, one that will lead to lower costs and help the region address the rising rates of cancer in an aging population.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In